Experience of Femoston Treatment in Perimenopausal Women Receiving Oral Corticosteroid Therapy

Cover Page


Cite item

Full Text

Abstract

Chronic oral corticosteroid therapy, which is widely used for the treatment of bronchial asthma, dermatological, rheumatic diseases, systemic diseases of the connective tissue, etc., is often a psychological obstacle to the appointment of hormone replacement therapy (HRT) for women in menopause. At the same time, the appointment of estrogenic drugs for this category of patients in some cases is necessary, since by reducing climacteric symptoms, stopping urogenital disorders and increasing the level of bone mass, HRT can significantly improve the quality of life.

About the authors

A. V. Dreval

Moscow Regional Research Clinical Institute named after M.F. Vladimirsky

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Moscow

L. A. Marchenkova

Moscow Regional Research Clinical Institute named after M.F. Vladimirsky

Email: info@eco-vector.com
Russian Federation, Moscow

E. Y. Polyakova

Moscow Regional Research Clinical Institute named after M.F. Vladimirsky

Email: info@eco-vector.com
Russian Federation, Moscow

I. V. Kryukova

Moscow Regional Research Clinical Institute named after M.F. Vladimirsky

Email: info@eco-vector.com
Russian Federation, Moscow

R. S. Tishenina

Moscow Regional Research Clinical Institute named after M.F. Vladimirsky

Email: info@eco-vector.com
Russian Federation, Moscow

N. D. Gasparyan

Moscow Regional Research Institute of Obstetrics and Gynecology

Email: info@eco-vector.com
Russian Federation, Moscow

D. V. Grigorieva

Moscow Regional Research Institute of Obstetrics and Gynecology

Email: info@eco-vector.com
Russian Federation, Moscow

A. V. Koroleva

Moscow Regional Research Institute of Obstetrics and Gynecology

Email: info@eco-vector.com
Russian Federation, Moscow

References

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig 1. Dynamics of MMI (points) during therapy with femoston

Download (13KB)
3. Fig 2. Dynamics of neuro-vegetative climacteric symptoms (points) during therapy with femoston

Download (13KB)
4. Fig 3. Dynamics of the average number of hot flashes per day during therapy with femoston

Download (12KB)
5. Fig 4. Dynamics of psycho-asthenic climacteric symptoms (points) during therapy with femoston

Download (12KB)
6. Fig 5. Dynamics of urogenital symptoms (points) during treatment with femoston

Download (14KB)

Copyright (c) 2003 Eсо-Vector



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies